Where Food Comes From, Inc. (WFCF) Q4 2024 Earnings Call Transcript — Neutral

WFCF   Seeking Alpha — February 21, 2025

Where Food Comes From, Inc. (NASDAQ:WFCF ) Q4 2024 Results Conference Call February 20, 2025 12:00 PM ET Company Participants Jay Pfeiffer - Investor Relations John Saunders - Chief Executive Officer Leann Saunders - President Dannette Henning - Chief Financial Officer Operator Welcome to Where Food Comes From 2024 Year-End Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

image for news Where Food Comes From, Inc. (WFCF) Q4 2024 Earnings Call Transcript

Norwegian oil and gas firm Equinor is looking to sell its onshore assets in Argentina's Vaca Muerta region, the Mas Energia online publication reported, citing unnamed sources.

image for news Equinor plans sale of onshore assets in Argentina, local news report says

Travere Therapeutics, Inc. (TVTX) Q4 2024 Earnings Call Transcript — Neutral

TVTX   Seeking Alpha — February 21, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Victoria Prescott - Manager of Investor Relations Eric Dube - President and CEO Jula Inrig - Chief Medical Officer Peter Heerma - Chief Commercial Officer Chris Cline - CFO William Rote - Senior Vice President of Research & Development Conference Call Participants Malcolm Kuno - JPMorgan Vamil Divan - Guggenheim Securities Joseph Schwartz - Leerink Partners Liisa Bayko - Evercore ISI Yigal Nochomovitz - Citigroup Prakhar Agrawal - Cantor Fitzgerald Fadi Ahman - Wells Fargo Gregory Harrison - Scotiabank Jason Zemansky - …

image for news Travere Therapeutics, Inc. (TVTX) Q4 2024 Earnings Call Transcript

Oceaneering's Q4 Earnings Miss Estimates, Revenues Beat — Negative

OII   Zacks Investment Research — February 21, 2025

OII expects net income to be between $160 million and $190 million, with consolidated EBITDA between $380 million and $430 million for 2025.

image for news Oceaneering's Q4 Earnings Miss Estimates, Revenues Beat

Cleveland-Cliffs to Post Q4 Earnings: What's in Store for the Stock? — Neutral

CLF   Zacks Investment Research — February 21, 2025

While CLF is expected to have benefited from actions to reduce costs, lower prices and weaker volumes are likely to have weighed on its Q4 performance.

image for news Cleveland-Cliffs to Post Q4 Earnings: What's in Store for the Stock?

Krystal Biotech's VYJUVEK shows strong growth, with 2025 sales expected to exceed $1B, bolstered by launches in the EU and Japan. Q4 earnings beat EPS expectations but slightly missed revenue forecasts; however, management's 2025 outlook coming catalysts drove a strong rally in shares. Key 2025 catalysts include VYJUVEK's EU and Japan launches, Phase 3 ocular DEB results, and progress in CF and lung gene therapy.

image for news Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus

Fourth Quarter Highlights: GAAP net income of $0.32 and distributable earnings of $0.40, per diluted common share1 Declares cash dividend on common stock of $0.43 per share Agency loan originations of $1.38 billion and a servicing portfolio of ~$33.47 billion Structured loan originations of $684.3 million, runoff of $900.6 million, and a portfolio of ~$11.30 billion Issued $100.0 million of 9.00% senior notes due 2027 Full Year Highlights: GAAP net income of $1.18 and distributable earnings of $1.74 per diluted common share1 Agency servicing portfolio growth of 8% from loan originations of $4.47 billion Successfully delevered the Company 30% from …

image for news Arbor Realty Trust Reports Fourth Quarter and Full Year 2024 Results and Declares Dividend of $0.43 per Share

3 Top Warren Buffett Stocks to Buy Right Now — Positive

AMZN  DPZ  KO   The Motley Fool — February 21, 2025

Warren Buffett has an unrivaled track record of creating piles of money. From 1965 through 2023, Buffett's knack for spotting value that Wall Street overlooks has grown the value of Berkshire Hathaway stock by 4,384,748%.

image for news 3 Top Warren Buffett Stocks to Buy Right Now

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. (“Pearsanta”), has engaged Dominari Securities LLC as lead underwriter for Pearsanta's planned initial public offering (IPO). The proposed IPO, advised by Dominari Securities, is intended to support Pearsanta's U.S. and international commercial launch efforts and.

image for news Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025

Northern's Q4 Earnings Lag Estimates, Revenues Increase Y/Y — Negative

NOG   Zacks Investment Research — February 21, 2025

NOG expects annual oil production in the range of 75,000-79,000 barrels per day and total production in the band of 130,000-135,000 Boe/d for 2025.

image for news Northern's Q4 Earnings Lag Estimates, Revenues Increase Y/Y

PagSeguro Digital Ltd. (PAGS) Q4 Earnings and Revenues Beat Estimates — Positive

PAGS   Zacks Investment Research — February 21, 2025

PagSeguro Digital Ltd. (PAGS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share.

image for news PagSeguro Digital Ltd. (PAGS) Q4 Earnings and Revenues Beat Estimates

Coinbase said on Friday the U.S. securities regulator planned to withdraw its lawsuit against the crypto exchange, ending a contentious years-long legal battle once considered existential for the trading platform and the broader sector.

image for news US securities regulator to drop lawsuit against Coinbase, exchange says

Palantir Stock Skids—How Much Further Can It Fall? — Neutral

PLTR   MarketBeat — February 21, 2025

Shares of Palantir Technologies Inc. NASDAQ: PLTR are down 17% in two trading sessions. For much of the last 18 months, Palantir has been like a boxer who continues to have opponents throw punches, none of which land with any effect.

image for news Palantir Stock Skids—How Much Further Can It Fall?

AI-Driven Advertising Has AppLovin Soaring — Positive

APP   FXEmpire — February 21, 2025

Shares of AppLovin, Corp. (APP), which operates a marketing platform and makes mobile apps, are up 685% in a year.

image for news AI-Driven Advertising Has AppLovin Soaring

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business o.

image for news Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025

2 S&P 500 ETFs for Growth and Leverage in a Hot Market — Neutral

SPUU  SPYG   MarketBeat — February 21, 2025

To put it mildly, it's been a very good couple of years for the S&P. Following a tepid 2022, the banner S&P 500 index has accelerated growth from 2023 into 2024.

image for news 2 S&P 500 ETFs for Growth and Leverage in a Hot Market

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? — Neutral

RXRX   MarketBeat — February 21, 2025

Recursion Pharmaceuticals' NASDAQ: RXRX stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken by artificial intelligence (AI) chip giant NVIDIA NASDAQ: NVDA. A recent SEC filing showed NVIDIA reshuffling its AI investment portfolio, and while it trimmed its holdings in several AI ventures, it notably maintained its stake in Recursion Pharmaceuticals.

image for news Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite?

The e-commerce stock has started 2025 on a tear, with investors betting that China's faltering economy will rebound.

image for news GameStop CEO Ups Alibaba Bet to $1 Billion. Why Earnings Wowed the Street.

Gold Mining ETF (GDXJ) Hits New 52-Week High — Positive

GDXJ   Zacks Investment Research — February 21, 2025

For investors seeking momentum, VanEck Junior Gold Miners ETF GDXJ is probably on the radar. The fund just hit a 52-week high and is up about 80% from its 52-week low price of $31.00/share.

image for news Gold Mining ETF (GDXJ) Hits New 52-Week High

NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options. NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.

image for news NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program